Sana Biotechnology, Inc. (SANA) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $938.0K | -97.2% |
| 2024 | $33.43M | +66.9% |
| 2023 | $20.03M | -4.0% |
| 2022 | $20.88M | -30.1% |
| 2021 | $29.86M | +25.1% |
| 2020 | $23.87M | -8.6% |
| 2019 | $26.12M | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $938.0K | -97.2% |
| 2024 | $33.43M | +66.9% |
| 2023 | $20.03M | -4.0% |
| 2022 | $20.88M | -30.1% |
| 2021 | $29.86M | +25.1% |
| 2020 | $23.87M | -8.6% |
| 2019 | $26.12M | — |